AzTrials
AzTrials

Threatened Preterm LabourNCT06752161

Urinary Infection in Pregnant Women with Urinary Infection

An observational study of Threatened Preterm Labour, run by Assiut University at 1 site in Egypt.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record

Search all trials

Trial summary

Urine analysis and culture in patients with threatened preterm labour Read more about this study

Who is it for?
Any age, women only
Conditions the study is for
Threatened Preterm Labour
What is being tested?
Urine analysis
How many people
224 participants
Where
1 siteEgypt
Study dates
1 Feb 2024to Jan 2027
Phase
Observational

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Patients with threatened preterm labor

Who may be able to join

  • pregnant women with preterm labor

Who cannot join

  • renal disease Intrauterine fetal death

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Egypt1 site, 1 recruiting
  • Women's Health Hospital

    Asyut

    Women Hospital, 0882414916, ethics_committee12@yahoo.com

    Recruiting

Other trials in Egypt

About this study

Official title: Urinary Tract Infections in Patients with Threatened Preterm Labor

Urine analysis and culture in patients with threatened preterm labour

Read the detailed description

UTI is an infection of the kidneys, bladder, or urethra. Infectious cystitis is the most common type of UTI, which is caused by a bacterial infection of the bladder. Lifetime incidence of UTIs is 50% to 60% in adult women.UTIs are among the most common conditions encountered in primary care, hospitals, and extended care facilities . Total direct costs of UTI treatment (without cultures) have been estimated at US $25.5 billion annually.Despite an exceptionally high prevalence of bacteriuria in the population, these infections rarely cause significant renal damage.Sexual intercourse is the strongest risk factor. Any lifetime sexual activity and any sexual activity during the past year are strongly associated with recurrent UTI. Even the relatively small amounts of spermicide coating condoms increases the risk of UTI. Post-menopausal absence of oestrogen is a risk factor for UTIs. Topical oestrogen reduces UTIs in post-menopausal women; Oestrogenisation of the vaginal mucosa promotes lactobacilli colonisation, which reduces the presence of uropathogens and thus the risk of UTIs and is not recommended over the use of topical oestrogen therapy. Urinary incontinence and oestrogen supplementation have also been associated with UTI in older women, although the reasons for this are incompletely understood. positive family history of UTIs is associated with a two- to fourfold increase in risk of recurrent UTI . Bacteriuria occurs in the presence of indwelling or intermittent catheters, and asymptomatic bacteriuria does not require treatment. Gestational and pregestational diabetes are considered a more predominant risk factor in older women.

Being tested
Urine analysis
Keywords
UTI, Preterm labour
Medical subject headings
Obstetric Labor, Premature

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Urine analysisOther

    Urine analysis and culture for Screening and diagnostic tools for UTI in pregnant women

Study groups in NCT06752161
Study groupRoleWhat they receive
Pregnant women with threatened preterm labourPatients with UTI and preterm labour
Receives: Other: Urine analysis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. percent of urinary tract infections in threatened preterm labor

    Percentage of women with threatened preterm labor diagnosed with urinary tract infection

    Measured: 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Dec 2024
  2. Study start1 Feb 2024
  3. Primary completionDec 2026 (estimated)
  4. Study completionJan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
224 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06752161
Sponsor's protocol ID
UTIP
Status last verified
Dec 2024
First submitted
20 Dec 2024
Last updated
4 Feb 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in